Does Amoxicillin Improve Outcomes in Patients with Purulent Rhinorrhea?

,

Original Research

Does Amoxicillin Improve Outcomes in Patients with Purulent Rhinorrhea?

J Fam Pract. 2002 April;51(4):317-323

PDF Download

References

1. Okkes IM, Oskam SK, Lamberts H. Van klacht naar diagnose. Episodegegevens uit de huisartspraktijk. Coutinho, Bussum, Nl; 1998.

2. De Maeseneer J. Het voorschrijven van antibiotica bij luchtwegproblemen. Een explorerend onderzoek. Huisarts Wet 1990;33:223-6.

3. De Melker RA, Kuyvenhove MM. Management of upper respiratory tract infection in Dutch general practice. Br J Gen Pract 1991;41:504-7.

4. van Buchem L, Peeters M, Beaumont J, Knottnerus JA. Acute maxillary sinusitis in general practice: the relation between clinical picture and objective findings. Eur J Gen Pract 1995;1:155-60.

5. Hansen JC, Schmidt H, Rosborg J, Lund E. Predicting acute maxillary sinusitis in a general practice population. BMJ 1995;311:233-6.

6. Stalman W, Van Essen GA, Gubbels JW, De Melker RA. Difficulties in diagnosing acute sinusitis in a Dutch group practice. Relative value of history, radiography and ultrasound. Eur J Gen Pract 1997;3:12-5.

7. Hueston WJ, Mainous AG, Dacus EN, Hopper JE. Does acute bronchitis really exist? A reconceptualization of acute viral respiratory infections. J Fam Pract 2000;49:401-6.

8. Ferranti de SD, Ioannidis JPA, Lau J, Anninger WV, Barza M. Are amoxicillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis. BMJ 1998;317:632-7.

9. Williams JW, Jr, Aguilar C, Makela M, et al. Antibiotic therapy for acute sinusitis: a systematic literature review. In: Douglas R, Bridges-Webb C, Glasziou P, Lozano J, Steinhoff M, Wang E, eds. Acute respiratory infections module of the Cochrane Database of Systematic Reviews. The Cochrane Library. Oxford, England: Updated Software; 1997.

10. Zucker DR, Balk E, Engels E, Barza M, Lau J. Agency for Health Care Policy and Research Publication No. 99-E016. Evidence report/technology assessment number 9. Diagnosis and treatment of acute bacterial rhinosinusitis. Available at www.ahrq.gov/clinic/sinussum.htm.

11. van Buchem FL, Knottnerus JA, Scrhrijnemaekers VJJ, Peeters MF. Primary-care-based randomised placebo-controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet 1997;349:683-7.

12. Lindbaek M, Hjortdahl P, Johnsen UL-H. Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ 1996;313:325-9.

13. Hansen JG, Schmidt H, Grinsted P. Randomised, double blind, placebo controlled trial of penicillin V in the treatment of acute maxillary sinusitis in adults in general practice. Scand J Prim Health Care 2000;18:44-7.

14. Haye R, Lingaas E, Hoivik HO, Odegard T. Azithromycin versus placebo in acute infectious rhinitis with clinical symptoms but without radiological signs of maxillary sinusitis. Eur J Clin Microbiol Infect Dis 1998;17:309-12.

15. Kaiser L, Lew D, Hirschel B, et al. Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet 1996;347:1507-10.

16. Stalman W, van Essen GA, van der Graaf Y, de Melker RA. The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice? A placebo-controlled double-blind randomized doxycycline trial. Br J Gen Pract 1997;47:794-9.

17. Axelsson A, Runze U. Symptoms and signs af acute maxillary sinusitis. ORL J Otorhinolaryngol Relat Spec 1976;38:298-308.

18. Berg O, Carenfelt C. Analysis of symptoms and clinical signs in the maxillary sinus empyema. Acta Otolaryngol (Stockholm) 1988;105:343-9.

19. Lindbaek M, Hjortdahl HR, Johnsen UL-H. Use of symptoms, signs and bloodtests to diagnose acute sinus infections in primary care: comparison with computed tomography. Fam Med 1996;28:181-6.

20. Van Duyn NP, Brouwer HJ, Lamberts H. Use of symptoms and signs to diagnose maxillary sinusitis in general practice: comparison with ultrasonography. BMJ 1992;305:684-7.

21. Williams JW, Simel DL, Leroy R, Samsa GP. Clinical evaluation for sinusitis. Making the diagnosis by history and physical examination. Ann Int Med 1992;117:705-10.

22. Axelsson A, Runze U. Comparison of subjective and radiological findings during the course of acute maxillary sinusitis. Ann Otol Rhinol Laryngol 1983;92:75-7.

23. Gonzales R, Barrett PH, Steiner JF. The relation between purulent manifestations and antibiotic treatment of upper respiratory tract infections. J Gen Intern Med 1999;14:151-6.

24. Little DR, Mann BL, Sherk DW. Factors influencing the clinical diagnosis of sinusitis. J Fam Pract 1998;46:147-52.

25. Mainous AG, Hueston WJ, Eberlein C. Colour of respiratory discharge and antibiotic use. Lancet 1997;350:1077.-

26. De Sutter AI, De Meyere MJ, De Maeseneer JM, Peersman WP. Antibiotic prescribing in acute infections of the nose or sinuses: a matter of personal habit? Fam Pract 2001;18:209-13.

27. Gray WC, Blanchard CL. Sinusitis and its complications. Am Fam Physician 1987;35:232-43.

28. Williams JW, Roberts L, Distell B, Simel DL. Diagnosing sinusitis by X-ray: is a single Waters view adequate? J Gen Intern Med 1992;7:481-5.

29. Piccirillo JF, Edwards D, Haiduk A, et al. Psychometric and clinimetric validity of the 31-item rhinosinusitis outcome measure (RSOM-31). Am J Rhinol 1995;9:297-306.

30. Bhattacharyya T, Piccirillo J, Wippold FJ, II. Relationships between patient-based descriptions of sinusitis and paranasal sinus computed tomographic findings. Arch Otolaryngol Head Neck Surg 1997;123:1189-92.

31. Altman DG. Practical statistics for medical research. London, England: Chapman & Hall; 1991;455-60.

32. De Meyere M. Acute keelpijn in de eerste lijn. [dissertatie]. 1990 Rijksuniversiteit Gent, Faculteit Geneeskunde.

33. Verheij TJM, Hermans J, Mulder JD. Effects of doxycycline in patients with acute cough and purulent sputum: a double blind placebo controlled trial. Br J Gen Pract 1994;44:400-4.

34. Burke P, Bain J, Robinson D, Dunleavy J. Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ 1991;303:558-62.

35. Damoiseaux RAMJ, Balen van FAM, Hoes AW, Melker de RA. Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ 2000;320:350-4.

36. Little P, Could C, Williamson I, Moore M, Warner G, Dunleavy J. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ 2001;322:336-42.

37. Little P, Williamson I, Warner G, Gould C, Gantley M, Kinmonth AL. Open randomised trial of prescribing strategies in managing sore throat. BMJ 1997;314:722-7.

38. Wilson S, Delaney BC, Roalfe A, et al. Randomised controlled trials in primary care: case study. BMJ 2000;321:24-7.

39. De Bock GH, Van Duijn NP, Dagnelie CF, et al. NHG-Standaard Sinusitis. Huisarts Wet 1993;36:255-7.

40. Low DE, Desrosiers M, McSherry J, et al. A practical guide for the diagnosis and treatment of acute sinusitis. CMAJ 1997;156(suppl 6):S1-14.

41. Snow V, Mottur-Pilson C, Hickner JM. Principle of appropriate antibiotic use for acute sinusitis in adults. Ann Intern Med 2001;134:495-7.

42. Pierard D, De Meyer A, Vanzeebroeck A, Lauwers S. In vitro evaluatie van de gevoeligheid van 205 recente klinische isolaten van streptococcus pneumoniae voor minocycline en andere antibiotica. Tijdschr Geneesk 1996;52:281-5.

In this trial, as in daily practice, we did not know the precise diagnosis of included patients. Moreover, despite our frequent requests, participating FPs included only a minority of eligible patients. Concern might arise that only patients with mild disease were studied. We made 3 efforts to verify that the population was truly representative. First, we determined that the personal characteristics and severity of symptoms of patients of low-recruiting FPs (who tend to include patients with worse symptoms³⁸) were no different from those of patients included by high recruiters. Second, an analysis of questionnaires from all eligible but excluded patients over a 6-week period showed that included and excluded patients were very much alike. The analysis also showed that in only 3% of patients did the FP consider the subject too ill to be included. Third, the results obtained on plain radiography of the maxillary sinuses were in line with the imaging results of other family practice populations with clinical suspicion of rhinosinusitis.^11,19-21

With regard to the methodology, we wish to clarify certain choices. Amoxicillin was selected because it is recommended as the first-line drug for rhinosinusitis in several practice guidelines^39-41 and the sensitivity of respiratory pathogens to it was sufficient in our geographic area at the start of the trial.⁴²* To evaluate symptoms, we chose the 20 items of the SNOT-20 questionnaire (Table 1), an abbreviated version of the RSOM-31,²⁹ a disease-specific quality-of-life test for sinusitis. These 20 items include not only all classic rhinosinusitis symptoms but also a number of more subjective symptoms, such as sleep disturbances and reduced productivity, which may also severely inconvenience patients. Any beneficial effect of amoxicillin on these symptoms would be just as important as an effect on the classic sinusitis symptoms.

Outcome measures were mainly self-assessed by patients, since in this kind of pathology, for which subjective inconvenience is often greater than objective signs might indicate, the patient is in our view the best and only judge of symptom improvement. The main outcome measure, disappearance of perceived worst symptoms, was designed to take into account the heterogeneity of clinical presentations.

Conclusions

Patients with an acute upper respiratory tract infection with purulent rhinorrhea (and without signs of complications of sinusitis) represent a large, clearly defined, clinically recognizable group. Our results show that amoxicillin provides no clinically important benefits for this population. The implication for practice is that whatever diagnosis is suspected, all these patients can safely be treated with symptomatic therapy only. Patients should, however, be informed that whichever treatment is chosen, symptoms can last for a long time. In the rare event that symptoms worsen, they should consult their FP for antibiotic therapy. If patients are clearly distressed by the purulent rhinorrhea itself, this trial suggests reasons for considering the use of amoxicillin, but potential patient benefits still probably do not outweigh the disadvantages.

* For an expanded version of this table, see Table W1.

ACKNOWLEDGMENTS

The authors wish to thank all participating family physicians and patients and Erna Eeckhout, Adrienne Dubron, Anselme Derese, MD, PhD, and John Marshall for their invaluable help.